Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Hydroxypyruvic acid lithium hydrate is an intermediate in the metabolism of serine, glycine, and threonine. It is a substrate for serine-pyruvate aminotransferase and glyoxylate reductase/hydroxypyruvate reductase.
説明 | Hydroxypyruvic acid lithium hydrate is an intermediate in the metabolism of serine, glycine, and threonine. It is a substrate for serine-pyruvate aminotransferase and glyoxylate reductase/hydroxypyruvate reductase. |
In vivo | Hydroxypyruvic acid ?(intravenous injection;?100 mg/ml;?slowly over 10 min) increases the 5-h urinary oxalate and glycolate excretion to 0.68% (6.56 μmol) and 0.53% (5.10 μmol) in control rats, in addition, it increases to 2.43% (23.36 μmol) and 0.79% (7.59 μmol) of the dose in the vitamin-B6-deficient rats. |
別名 | β-Hydroxypyruvic acid lithium hydrate, 3-Hydroxypyruvic acid lithium hydrate |
分子量 | 129.02 |
分子式 | C3H6LiO5 |
CAS No. | 209728-15-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Hydroxypyruvic acid lithium hydrate 209728-15-4 Others β-Hydroxypyruvic acid lithium hydrate Hydroxypyruvic acid lithium Hydrate beta-Hydroxypyruvic acid lithium Hydrate 3-Hydroxypyruvic acid lithium hydrate b-Hydroxypyruvic acid lithium Hydrate 3-Hydroxypyruvic acid lithium Hydrate β-Hydroxypyruvic acid lithium Hydrate Inhibitor inhibitor inhibit